Plasmodium falciparum clearance with artemisinin-based combination therapy (ACT) in patients with glucose-6-phosphate dehydrogenase deficiency in Mali
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Plasmodium falciparum clearance with artemisinin-based combination therapy (ACT) in patients with glucose-6-phosphate dehydrogenase deficiency in Mali ; volume:9 ; number:1 ; day:21 ; month:11 ; year:2010 ; pages:1-7 ; date:12.2010
Malaria journal ; 9, Heft 1 (21.11.2010), 1-7, 12.2010
- Creator
-
Kone, Abdoulaye K.
- Contributor
-
Sagara, Issaka
Théra, Mahamadou A.
Dicko, Alassane
Guindo, Aldiouma
Diakite, Seidina
Kurantsin-Mills, Joseph
Djimde, Abdoulaye
Walcourt, Asikiya
Doumbo, Ogabara
SpringerLink (Online service)
- DOI
-
10.1186/1475-2875-9-332
- URN
-
urn:nbn:de:1111-2016080623844
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kone, Abdoulaye K.
- Sagara, Issaka
- Théra, Mahamadou A.
- Dicko, Alassane
- Guindo, Aldiouma
- Diakite, Seidina
- Kurantsin-Mills, Joseph
- Djimde, Abdoulaye
- Walcourt, Asikiya
- Doumbo, Ogabara
- SpringerLink (Online service)
Other Objects (12)
Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Early variations in plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance
Parasite reduction ratio one day after initiation of artemisinin-based combination therapies and its relationship with parasite clearance time in acutely malarious children
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Plasmodium falciparum kelch13 polymorphisms identified after treatment failure with artemisinin-based combination therapy in Niger
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Molecular assessment of atpase6 mutations associated with artemisinin resistance among unexposed and exposed Plasmodium falciparum clinical isolates to artemisinin-based combination therapy
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments—a WWARN individual patient data meta-analysis
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Early variations in plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance
Parasite reduction ratio one day after initiation of artemisinin-based combination therapies and its relationship with parasite clearance time in acutely malarious children
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Plasmodium falciparum kelch13 polymorphisms identified after treatment failure with artemisinin-based combination therapy in Niger
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Molecular assessment of atpase6 mutations associated with artemisinin resistance among unexposed and exposed Plasmodium falciparum clinical isolates to artemisinin-based combination therapy
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments—a WWARN individual patient data meta-analysis
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Early variations in plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance
Parasite reduction ratio one day after initiation of artemisinin-based combination therapies and its relationship with parasite clearance time in acutely malarious children
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Plasmodium falciparum kelch13 polymorphisms identified after treatment failure with artemisinin-based combination therapy in Niger
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Molecular assessment of atpase6 mutations associated with artemisinin resistance among unexposed and exposed Plasmodium falciparum clinical isolates to artemisinin-based combination therapy
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments—a WWARN individual patient data meta-analysis